Cargando…

Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones

Chronic Lymphocytic Leukemia (CLL) is a lymphoproliferative disorder with either indolent or aggressive clinical course. Current treatment regiments have significantly improved the overall outcomes even if higher risk subgroups - those harboring TP53 mutations or deletions of the short arm of chromo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carrà, Giovanna, Panuzzo, Cristina, Torti, Davide, Parvis, Guido, Crivellaro, Sabrina, Familiari, Ubaldo, Volante, Marco, Morena, Deborah, Lingua, Marcello Francesco, Brancaccio, Mara, Guerrasio, Angelo, Pandolfi, Pier Paolo, Saglio, Giuseppe, Taulli, Riccardo, Morotti, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Priority Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482594/ https://www.ncbi.nlm.nih.gov/pubmed/28418900 http://dx.doi.org/10.18632/oncotarget.16348

Ejemplares similares

The Role of PTEN in Myeloid Malignancies
por: Morotti, Alessandro, et al.
Publicado: (2015)

BCR-ABL Promotes PTEN Downregulation in Chronic Myeloid Leukemia
por: Panuzzo, Cristina, et al.
Publicado: (2014)

The targetable role of herpes virus-associated ubiquitin-specific protease (HAUSP) in p190 BCR-ABL leukemia
por: Carrà, Giovanna, et al.
Publicado: (2016)

The BCR-ABL/NF-κB signal transduction network: a long lasting relationship in Philadelphia positive Leukemias
por: Carrà, Giovanna, et al.
Publicado: (2016)

The non-genomic loss of function of tumor suppressors: an essential role in the pathogenesis of chronic myeloid leukemia chronic phase
por: Crivellaro, Sabrina, et al.
Publicado: (2016)

Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias
por: Morotti, Alessandro, et al.
Publicado: (2015)

Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBα mediated p53 nuclear exclusion
por: Crivellaro, Sabrina, et al.
Publicado: (2015)

IκB-α: At the crossroad between oncogenic and tumor-suppressive signals
por: Morotti, Alessandro, et al.
Publicado: (2017)

Mechanisms of p53 Functional De-Regulation: Role of the IκB-α/p53 Complex
por: Carrà, Giovanna, et al.
Publicado: (2016)

Inhibition of bromodomain and extra‐terminal proteins increases sensitivity to venetoclax in chronic lymphocytic leukaemia
por: Carrà, Giovanna, et al.
Publicado: (2019)

The ISG15-specific protease USP18 regulates stability of PTEN
por: Mustachio, Lisa Maria, et al.
Publicado: (2016)

Tumor Suppressors in Chronic Lymphocytic Leukemia: From Lost Partners to Active Targets
por: Andreani, Giacomo, et al.
Publicado: (2020)

IκBα targeting promotes oxidative stress-dependent cell death
por: Carrà, Giovanna, et al.
Publicado: (2021)

PML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity
por: Noguera, Nélida Inés, et al.
Publicado: (2016)

A negative feedback regulatory loop between miR-138 and TP53 is mediated by USP10
por: Luo, Zhenghua, et al.
Publicado: (2019)

New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia
por: Panuzzo, Cristina, et al.
Publicado: (2015)

Tumor suppressors revival in CLL
por: Carrà, Giovanna, et al.
Publicado: (2017)

Regulation of XPC deubiquitination by USP11 in repair of UV-induced DNA damage
por: Shah, Palak, et al.
Publicado: (2017)

The deubiquitinase USP54 is overexpressed in colorectal cancer stem cells and promotes intestinal tumorigenesis
por: Fraile, Julia M., et al.
Publicado: (2016)

Nuclear-cytoplasmic Shuttling in Chronic Myeloid Leukemia: Implications in Leukemia Maintenance and Therapy
por: Carrà, Giovanna, et al.
Publicado: (2019)

Remote intracranial recurrence of IDH mutant gliomas is associated with TP53 mutations and an 8q gain
por: Nakae, Shunsuke, et al.
Publicado: (2017)

Comparison of SARS-CoV-2 RT-PCR on a high-throughput molecular diagnostic platform and the cobas SARS-CoV-2 test for the diagnostic of COVID-19 on various clinical samples
por: Opota, Onya, et al.
Publicado: (2020)

Deubiquitination and stabilization of PTEN by USP13
por: Zhang, Jinsong, et al.
Publicado: (2013)

Synthetic lethality of a cell-penetrating anti-RAD51 antibody in PTEN-deficient melanoma and glioma cells
por: Turchick, Audrey, et al.
Publicado: (2019)

Non-Coding RNAs: The “Dark Side Matter” of the CLL Universe
por: Lingua, Marcello Francesco, et al.
Publicado: (2021)

Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy
por: Darb-Esfahani, Silvia, et al.
Publicado: (2016)

Novel combinations of PI3K-mTOR inhibitors with dacomitinib or chemotherapy in PTEN-deficient patient-derived tumor xenografts
por: Brana, Irene, et al.
Publicado: (2017)

Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibition
por: Wilson, Catherine, et al.
Publicado: (2014)

Estrogen receptor alpha drives proliferation in PTEN-deficient prostate carcinoma by stimulating survival signaling, MYC expression and altering glucose sensitivity
por: Takizawa, Itsuhiro, et al.
Publicado: (2014)

A new class of small molecule estrogen receptor-alpha antagonists that overcome anti-estrogen resistance
por: Ma, Yongxian, et al.
Publicado: (2015)

Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapy
por: Lyons, Yasmin A., et al.
Publicado: (2017)

Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic cancer therapeutic
por: Ohman, Kerri A., et al.
Publicado: (2016)

AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis
por: Mi, Wenting, et al.
Publicado: (2015)

Overcoming resistance to single-agent therapy for oncogenic BRAF gene fusions via combinatorial targeting of MAPK and PI3K/mTOR signaling pathways
por: Jain, Payal, et al.
Publicado: (2017)

Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAF(V600E)
por: Antonello, Zeus A., et al.
Publicado: (2017)

Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease
por: Lamb, Rebecca, et al.
Publicado: (2015)

The Challenge of Hemorrhagic Shock Management During Low-Molecular-Weight Heparin Treatment
por: Morotti, Alessandro, et al.
Publicado: (2020)

Future perspectives from lung cancer pre-clinical models: new treatments are coming?
por: Bersani, Francesca, et al.
Publicado: (2020)

Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable targets in atypical chronic myeloid leukemia
por: Rocca, Stefania, et al.
Publicado: (2018)

Shedding Light on NF-κB Functions in Cellular Organelles
por: Carrà, Giovanna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_233mtf03eat7hl9lam1qp9upms